oppløsning i ferdigfylt sprøyte

DRUG3 trials

Sponsors

Akershus University Hospital, Oslo University Hospital HF

Conditions

CancerColorectal cancerPancreatic ductal cancer

Phase 2

METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer – Shaping Anti-Tumor Immunity by Oxaliplatin

Active, not recruitingCTIS2022-500027-76-00

Akershus University HospitalColorectal cancer

Start: 2022-10-05Target: 40Updated: 2025-05-28

Improving public cancer care by implementing precision medicine in Norway A multi-cohort phase 2 treatment clinical study investigating efficacy of approved drugs outside indication in patients with advanced cancer. IMPRESS-Norway

RecruitingCTIS2023-507894-16-00

Oslo University Hospital HFCancer

Start: 2021-04-01Target: 6000Updated: 2026-01-22

Phase 3

Antiplatelet therapy added to standard thromboprophylaxis to prevent thrombosis in pancreatic cancer patients - a randomized clinical trial (The PANART trial)

RecruitingCTIS2023-509022-22-00

Akershus University HospitalPancreatic ductal cancer

Start: 2025-08-21Target: 744Updated: 2025-10-16